Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Anti-Cancer Drugs|April 23, 2005
A novel anti-pancreatic cancer agent, LY293111Xian-Zhong Ding, Marks S Talamonti, Richard H Bell, et al.
Expert Review of Anticancer Therapy|August 26, 2003
Lipoxygenase inhibitors for the treatment of pancreatic cancerTimothy J Kennedy, Chung-Yip Chan, Xian-Zhong Ding, et al.
Cancer Treatment Reviews|January 8, 2026
Mechanisms and biomarkers for musculoskeletal signs and symptoms in patients treated with aromatase inhibitors: A comprehensive systematic reviewNoora Jatan, Sami Talo, Aida J Azar, et al.
Peptides|February 5, 2002
Pancreatic polypeptide in pancreatitisRené Hennig, Panagiotis B Kekis, Helmut Friess, et al.
Molecular and Cellular Endocrinology|November 15, 2003
Amylin gene expression mediated by cAMP/PKA and transcription factors HNF-1 and NFYMichael W Cluck, Leon O Murphy, Jody Olson, et al.
Diseases of the Colon and Rectum|March 25, 2005
Time-course of morphologic changes and peptide YY adaptation in ileal mucosa after loop ileostomy in humansNahm-Gun Oh, Gyung-Mo Son, Jin-Yong Sin, et al.
Anti-Cancer Drugs|April 7, 2007
Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cellsWei-Gang Tong, Xian-Zhong Ding, Mark S Talamonti, et al.
Biochemical and Biophysical Research Communications|August 18, 2005
LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathwaysWei-Gang Tong, Xian-Zhong Ding, Mark S Talamonti, et al.
Cancer Biology & Therapy|May 24, 2005
Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistantTarek H el-Metwally, Mahmoud R Hussein, Parviz M Pour, et al.
Cancer Biology & Therapy|June 23, 2005
High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitroTarek H El-Metwally, Mahmoud R Hussein, Parviz M Pour, et al.
Pageof 8